潜在的蛋白质激酶抑制剂,向人类端粒区域的G-四重复 DNA 结构
Bhavya Banjan1, Abel John Koshy1, Haritha Kalath1
1Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to Be University), Mangalore, Karnataka, 575018, India.
Molecular diversity
|March 21, 2024
概括
一些FDA批准的激酶抑制剂,如Ponatinib和Lapatinib,显示出稳定G-四重复 (G4) DNA结构的潜力. 这种稳定可能通过提高药物疗效,为癌症治疗提供新的策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 富含关氨酸的端粒序列形成G-四重复 (G4) DNA结构,其稳定是由.
- G4DNA通过调节瘤基因和瘤抑制基因在癌症中发挥作用.
研究的目的:
- 研究FDA批准的蛋白质激酶抑制剂,以确定它们稳定人类端粒G4DNA的能力.
- 探索重新利用这些抑制剂作为一种新的癌症治疗策略.
主要方法:
- 分子对接被用来评估16个人类端粒G4DNA标和71个FDA批准的蛋白激酶抑制剂之间的结合亲和关系.
- 进行了具有约束力的自由能量计算和分子动力学模拟,以确认结合的有效性和稳定性.
主要成果:
- 波纳提尼布和拉帕提尼布与所有16个向G4DNA结构的相互作用.
- 计算分析证实了ponatinib和lapatinib与G4DNA结合的有效性和稳定性.
结论:
- 波纳提尼布和拉帕提尼布可能会稳定人类端粒G4DNA,可能有助于它们的抗癌作用.
- 这种G4DNA稳定可能代表这些激酶抑制剂在癌症治疗中的额外作用机制.
相关概念视频
Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
DNA Helicases
21.3K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
21.3K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Single-Strand DNA Binding Proteins
14.1K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
14.1K


